menu
    • menu

    Company profile for Galderma

    NEW Drugs in Dev: 35
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of...
    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GaldermaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    World Trade Center, Avenue Gratta-Paille 2, 1018 Lausanne
    Telephone
    Telephone
    +41 21 642 78 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.galderma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/galderma-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/galderma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TOXINS 2026 Highlights Advances in Galderma Neuromodulators
    TOXINS 2026 Highlights Advances in Galderma Neuromodulators

    14 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260113854672/en/TOXINS-2026-Clinical-Updates-on-Galdermas-Leading-Neuromodulator-Portfolio-Further-Reinforce-Its-Leadership-in-Injectable-Aesthetics

    BUSINESSWIRE
    14 Jan 2026
    Share Share
    Nemluvio Eases Itch And Enhances Sleep In Atopic Dermatitis
    Nemluvio Eases Itch And Enhances Sleep In Atopic Dermatitis

    17 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-17/new-published-data-confirms-nemluvio-nemolizumab-can-rapidly-relieve-itch-and-improve-sleep-in-as

    PHARMIWEB
    17 Dec 2025
    Share Share
    Galderma Initiates Study On Nemolizumab For Chronic Pruritus
    Galderma Initiates Study On Nemolizumab For Chronic Pruritus

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/galderma-announces-first-patient-enrollment-in-study-to-assess-nemolizumab-in-adults-with-chronic-pr

    PHARMIWEB
    11 Dec 2025
    Share Share
    Galderma Welcomes Increased Equity Investment From L’Oréal
    Galderma Welcomes Increased Equity Investment From L’Oréal

    08 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251207921992/en/Galderma-Welcomes-Increased-Equity-Investment-From-LOral

    BUSINESSWIRE
    08 Dec 2025
    Share Share
    Galderma Secures 'BBB' Rating, Positive S&P Outlook
    Galderma Secures 'BBB' Rating, Positive S&P Outlook

    04 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251203014636/en/Galderma-Secures-BBB-Credit-Rating-With-Positive-Outlook-from-SP-Global-Ratings

    BUSINESSWIRE
    04 Dec 2025
    Share Share
    Galderma Showcases Innovative Aesthetic Injectables Portfolio
    Galderma Showcases Innovative Aesthetic Injectables Portfolio

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251116115085/en/ASDS-2025-Compelling-New-Data-on-Restylane-Sculptra-and-Relfydess-Highlight-Galdermas-Innovative-Injectable-Aesthetics-Portfolio-and-Pipeline

    BUSINESSWIRE
    17 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search